Purple Style Labs IPO Day 2 Subscription Status: 0.16x Subscribed; GMP at ₹5

Purple Style Labs’ Initial Public Offering (IPO) was subscribed 0.16 times as of late morning on Day 2 (11:00 a.m. to 12:00 noon IST on 1 September 2026). Retail Individual Investors led demand at 0.72x, while institutional participation remained limited. The latest available Grey Market Premium (GMP) was around ₹5, although another tracker showed ₹7. The ₹680 crore issue remains open until 2 September 2026.
| Metric | Latest update |
| Bidding day | Day 2 |
| Data status | Late morning (11:00 a.m. to 12:00 noon IST) on 1 September 2026 |
| Overall subscription | 0.16x |
| Qualified Institutional Buyers | 0.01x |
| Non-Institutional Investors | 0.07x |
| Retail Individual Investors | 0.72x |
| Current GMP | ₹5 |
| Other available GMP reading | ₹7 |
| GMP percentage at ₹5 | 0.9% |
| Indicative price at ₹5 GMP | ₹580 |
| Closing date | 2 September 2026 |
Purple Style Labs IPO Day 2 Subscription Status
Purple Style Labs’ public issue had received bids for about 16% of the shares available for subscription at the latest verified Day 2 snapshot.
| Investor category | Day 2 | Day 1 close | Change |
| Qualified Institutional Buyers (QIBs) | 0.01x | 0.01x | Unchanged |
| Non-Institutional Investors (NIIs) | 0.07x | 0.06x | +0.01x |
| Retail Individual Investors | 0.72x | 0.56x | +0.16x |
| Overall | 0.16x | 0.12x | +0.04x |
Retail remained the strongest category, rising to 0.72x from 0.56x at the Day 1 close. Non-Institutional Investor (NII) demand increased slightly to 0.07x, while Qualified Institutional Buyer (QIB) participation remained at 0.01x.
These multiples measure the quantity of shares bid for relative to each category’s reserved allocation. They do not represent the number of unique applicants.
How Subscription Changed From Day 1
Purple Style Labs IPO closed Day 1 at 0.12x overall and had moved to 0.16x overall by the latest Day 2 reading, an absolute increase of 0.04 times.
Retail investors were the main driver of the increase. Their subscription rose by 0.16 times, while NII demand advanced by only 0.01 times and QIB demand was unchanged.
The demand pattern therefore remains concentrated rather than broad-based. Retail investors have 10% of the net offer reserved for them, compared with 15% for NIIs and 75% for QIBs. A higher retail multiple should be interpreted in the context of that smaller allocation.
Institutional participation often builds later in the bidding period, but the current numbers do not establish that QIB demand will accelerate on the closing day.
Purple Style Labs IPO GMP Today and Estimated Listing Price
The latest available Purple Style Labs IPO GMP is around ₹5 per share, while another credible tracker showed a reading of ₹7. The difference highlights the unofficial nature of the grey market.
Using the ₹5 reading:
| GMP metric | Value |
| Current GMP used for calculation | ₹5 |
| Another available tracker | ₹7 |
| Previous available ₹5 reading | ₹5 |
| Direction versus ₹5 reading | Unchanged |
| Upper price band | ₹575 |
| GMP percentage | 0.9% |
| Indicative price | ₹580 |
The indicative price calculation is:
₹575 upper price band + ₹5 GMP = ₹580
The GMP percentage is:
₹5 ÷ ₹575 × 100 = approximately 0.9%
The current premium is also well below the higher pre-opening readings seen before bidding began. This indicates that grey-market expectations have moderated during the IPO period.
GMP is unofficial, unregulated, and can change quickly. It does not guarantee that Purple Style Labs shares will list at ₹580, or that investors will make a listing gain.
What Stands Out in Today’s Bidding
The first notable signal is the continued concentration of demand in retail. Retail subscription has moved closer to full coverage, but the overall issue remains only 0.16x subscribed because demand in the much larger QIB allocation is still minimal.
Second, subscription has improved from Day 1, while the GMP remains near the low-single-digit rupee range. That creates a useful subscription-GMP divergence: formal bidding has increased, but the unofficial premium has not strengthened alongside it.
There are also clear limitations. Day 2 bidding is still in progress, and institutional orders can arrive later. More importantly, neither subscription multiples nor GMP establish whether the company’s valuation is reasonable, whether its business quality justifies the offer price, or how the shares will perform after listing.
IPO Details Retail Investors Need
| IPO detail | Purple Style Labs IPO |
| Price band | ₹546 to ₹575 per share |
| Lot size | 26 shares |
| Minimum retail investment | ₹14,950 |
| Issue size | ₹680 crore |
| Fresh issue | ₹680 crore |
| Offer for Sale (OFS) | Nil |
| Issue type | Book-built mainboard IPO |
| Closing date | 2 September 2026 |
| Expected listing date | 7 September 2026 |
| Exchange | BSE and NSE |
The minimum retail application is one lot of 26 shares. At the upper price band of ₹575, one lot requires an investment of ₹14,950.
Brief Company and Financial Context
Purple Style Labs operates Pernia’s Pop-Up Shop, an omnichannel luxury fashion platform offering designer apparel, jewellery, accessories, and related products through online channels and physical Experience Centers.
Revenue from operations increased to ₹557.84 crore in FY2026 from ₹489.91 crore in FY2025. However, the company’s net loss widened to about ₹285.40 crore from ₹188.38 crore over the same period. Around ₹371.13 crore of fresh-issue proceeds is intended for lease-related expenditure through subsidiary PSL Retail, while ₹138.90 crore is earmarked for sales and marketing.
The widening losses, higher borrowings, and execution costs associated with expanding physical Experience Centers remain important considerations alongside growth in revenue from operations.
What Happens Next
Purple Style Labs IPO enters its closing day on 2 September 2026. Investors tracking the issue should watch whether overall subscription accelerates, whether QIB participation develops from its current low base, whether NII demand strengthens, and whether retail crosses full subscription.
The GMP direction is also worth monitoring because the current ₹5 to ₹7 range is substantially below earlier pre-opening levels.
Frequently Asked Questions (FAQs)
Q: How many times is the Purple Style Labs IPO subscribed on Day 2?
A: Purple Style Labs IPO was subscribed 0.16x overall as of late morning (11:00 a.m. to 12:00 noon IST) on 1 September 2026. Retail investors led the category-wise demand at 0.72x.
Q: How did Purple Style Labs IPO demand change from Day 1 to Day 2?
A: Overall subscription increased from 0.12x at the Day 1 close to 0.16x in the latest Day 2 snapshot. Retail demand was the main driver, rising from 0.56x to 0.72x.
Q: What is the Purple Style Labs IPO GMP today?
A: The latest available GMP is around ₹5 per share, while another tracker showed ₹7. GMP figures can differ because the grey market is unofficial and unregulated.
Q: What listing price does the current Purple Style Labs IPO GMP indicate?
A: At a ₹5 GMP and ₹575 upper price band, the indicative price is ₹580 per share. Using the separate ₹7 reading would imply ₹582. Neither figure is a guaranteed listing price.
Q: Does higher IPO subscription guarantee a premium listing?
A: No. Subscription measures bid quantity relative to shares offered. It does not guarantee a premium listing, fair valuation, business quality, or future returns. GMP is also only an unofficial market indicator.
Disclaimer
The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.







